Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-74.79	-472.93	1875.60
Graham Fair Price	41.42	1.39	0.98
PEG	-64.44	< 0.005	< 0.005
Price/Book	-6.67	0.03	0.03
Price/Cash Flow	-20.45	0.28	0.35
Prices/Earnings	53.33	-0.08	-0.17
Price/Sales	-53.33	0.69	1.49
Price/FCF	-20.45	0.28	0.35
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	10.98	0.68	0.62
Operating Margin	-302.18	-0.23	-0.06
ROA	-100.00	-0.03	-0.01
ROE	-0.05	-0.10	-100.00
ROIC	< 0.005	< 0.005	-555.83
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	-0.03	-0.10	75.19
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.97	-7.04	629.82
EPS QOQ	0.76	-1.00	31.22
FCF QOQ	1.72	0.17	-89.93
Revenue QOQ	-0.53	1.00	90.20
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	3581.83	100.00
Days Sales Outstanding (DSO)	426.74	303.56	-28.86
Inventory Turnover	0.00	0.03	100.00
Debt/Capitalization	0.62	0.61	-1.00
Quick Ratio	0.06	-1.10	1811.29
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	0.95	0.95	< 0.005
Cash	0.02	-2.38	10843.69
Capex	< 0.005	< 0.005	-100.00
Free Cash Flow	0.08	0.10	17.33
Revenue	0.02	0.04	100.00
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	0.37	0.37	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	1838.97	-464.07	-74.76
Naive Interpretation	Member

06 - Financial Health · Bad

Rating